Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jindan Yu

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Cancer Research|September 9, 2011
Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancerChunpeng Zhang, Liguo Wang, Dayong Wu, et al.
The Journal of Clinical Investigation|December 5, 2018
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionBing Song, Su-Hong Park, Jonathan C Zhao, et al.
Cancer Research|September 17, 2008
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancerBo Han, Rohit Mehra, Saravana M Dhanasekaran, et al.
Cancer Research|April 7, 2019
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate CancerShangze Li, Ka-Wing Fong, Galina Gritsina, et al.
Nature Communications|February 7, 2018
BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1Sen Zhu, Dongyu Zhao, Lin Yan, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Cell Reports|March 9, 2017
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon ResponseAbdul S Qadir, Paolo Ceppi, Sonia Brockway, et al.
Oncogene|August 30, 2019
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancerSen Zhu, Dongyu Zhao, Chao Li, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Science Advances|April 8, 2021
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancerSu H Park, Ka-Wing Fong, Jung Kim, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Cancer Research|September 9, 2011
Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancerChunpeng Zhang, Liguo Wang, Dayong Wu, et al.
The Journal of Clinical Investigation|December 5, 2018
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionBing Song, Su-Hong Park, Jonathan C Zhao, et al.
Cancer Research|September 17, 2008
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancerBo Han, Rohit Mehra, Saravana M Dhanasekaran, et al.
Cancer Research|April 7, 2019
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate CancerShangze Li, Ka-Wing Fong, Galina Gritsina, et al.
Nature Communications|February 7, 2018
BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1Sen Zhu, Dongyu Zhao, Lin Yan, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Cell Reports|March 9, 2017
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon ResponseAbdul S Qadir, Paolo Ceppi, Sonia Brockway, et al.
Oncogene|August 30, 2019
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancerSen Zhu, Dongyu Zhao, Chao Li, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Science Advances|April 8, 2021
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancerSu H Park, Ka-Wing Fong, Jung Kim, et al.
Pageof 13